Filter Results
:
(69)
Show Results For
-
All HBS Web
(111)
- News (22)
- Research (69)
- Events (1)
- Multimedia (3)
- Faculty Publications (48)
Show Results For
-
All HBS Web
(111)
- News (22)
- Research (69)
- Events (1)
- Multimedia (3)
- Faculty Publications (48)
←
Page 4 of
69
Results
Sort by
- 18 Aug 2017
- Op-Ed
Op-Ed: Courageous Leader Triggers a Moral Revolt of CEOs Against Trump
companies like Frazier and Merck got from the President. Their companies have products dependent on government approvals and major regulatory issues before Congress and the administration. Given these issues, what does it take for a CEO...
View Details
Keywords:
by Bill George
- 01 May 2007
- First Look
First Look: May 1, 2007
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=207113 Strategy in the 21st Century Pharmaceutical Industry: Merck & Co. and Pfizer Inc. Harvard Business School Case 707-509 The global pharmaceutical industry has gone...
View Details
Keywords:
Sean Silverthorne
- 31 Jul 2012
- First Look
First Look: July 31
Confidential Instructions for Johnson & Johnson Guhan Subramanian and Rhea GhoshHarvard Business School Exercise 911-045 This two-party negotiation exercise features a real-life dispute between Merck and Johnson & Johnson...
View Details
Keywords:
Carmen Nobel
- 14 Dec 2020
- Research & Ideas
What Does December's Drug-Approval Dash Mean for COVID-19 Vaccines?
[Image: aleksejplatonov] Related Reading The COVID Gender Gap: Why Fewer Women Are Dying COVID's Surprising Toll on Careers of Women Scientists Merck CEO Ken Frazier Discusses a COVID Cure, Racism, and Why Leaders Need to Walk the Talk...
View Details
- 30 May 2007
- Research & Ideas
Health Care Under a Research Microscope
including Bohmer, a physician; Bill George, former chairman and CEO of Medtronic; Raymond Gilmartin, former chairman, president, and CEO of Merck & Co.; Robert Huckman, a former health care consultant and now Faculty Research Fellow...
View Details
- 07 Feb 2005
- Research & Ideas
How “Career Imprinting” Shapes Leaders
career paths in biotech. For example, people who had worked at Merck and had cultivated Merck's "scientific career imprint" were more likely to take on leadership positions in young biotech firms by sitting on the boards of...
View Details
Keywords:
by Mallory Stark